Background. IgA nephropathy (IgAN) is the leading cause of end-stage renal disease (ESRD) in China considering different compositions of ESRD causes in different ethnicities. A recent genome-wide association study (GWAS) indicated that the MYH9 gene was significantly associated with non-diabetic ESRD in African-Americans and also influenced kidney function in Europeans. Thus, in the present study, we aim to clarify whether MYH9 confers a shared mechanism among different causes of ESRD and to seek possible further insight into our understanding of IgAN by applying GWAS data from ESRD to IgAN. Methods. One thousand one hundred and sixteen Chinese, including 527 patients with renal biopsy-proven IgAN and 589 healthy controls, were enrolled in the present study. Four single neucleotide polymorphisms (SNPs) (rs3752462, rs4821480, rs11089788 and rs2413396) reported to be associated with ESRD with the most significance were genotyped by TaqMan assay or a restriction fragment length polymorphism assay for a further casecontrol study. Results. None of the four SNPs was associated with the susceptibility to IgAN or clinical and pathological characters at the time of renal biopsy. However, estimated glomerular filtration rate decline rate was associated with rs11089788 in the dominant model (P = 0.021). Cox regression showed that rs11089788 (hazard ratio, 3.95; 95% confidence interval, 1.23-12.63; P = 2.1 3 10 À2 ) was an independent predictive factor for renal survival. Conclusions. Based on a large Chinese IgAN cohort, we found an association between rs11089788 and prognosis of IgAN, adding to the mounting evidence of MYH9 as an important gene in IgAN to ESRD.
Introduction
IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis in the world [1] . About 15-40% of patients develop end-stage renal disease (ESRD) requiring renal replacement therapy, typically through a slow progression of renal insufficiency !10 years [2] . The pathogenesis and progressive mechanisms of IgA nephropathy remain obscure. Genetic factors are generally considered to be involved in IgAN, according to the ethnic and geographical variations in prevalence [1] , as well as to the worldwide reported familial clustering of IgAN [3, 4] .
For the progression of renal diseases, recent research indicates that intact actin cytoskeleton is a prerequisite to maintain normal podocyte cytoarchitecture and filtration barrier function [5] . The nonmuscle myosin, the product of the nonmuscle myosin heavy chain 9 (MYH9) gene, presents in essentially every cell and binds to actin cytoskeleton to perform intracellular motor functions [6] . Previous studies on MYH9 mutations involving a number of kidney diseases (May-Hegglin, Epstein, Fechtner and Sebastian syndromes) indicated an association between MYH9 mutations and podocyte injury, which suggested that any alternations of the nonmuscle myosin, or changes in MYH9 expression or protein structure, will damage the glomerular filtration barrier, leading to proteinuria and/or haematuria and even renal failure [7, 8] . And more recently, a genome-wide association study (GWAS) identified MYH9 as a major susceptibility gene for ESRD, in various types of nephropathy (idiopathic focal segmental glomerulosclerosis, HIV-associated nephropathy and hypertension) and different ethnicities (African-Americans, Europeans and Hispanic Americans) [9] [10] [11] [12] . However, there are still no investigations regarding the role of MYH9 genetic variation or mutation in IgAN, which is the most prevalent primary glomerulonephritis and the primary cause of ESRD in Asians.
Replication study as a powerful approach to evaluate the validity of an association deserves at least one additional population, especially of different origin. In this regard, the association of identified risk alleles of MYH9 with IgAN was validated in a Chinese population in the current study. We aim to clarify whether it confers a shared mechanism among different causes of ESRD and provide further insight into our understanding of IgAN.
Subjects and methods

Subjects
In total, 1116 Chinese, including 527 patients with renal biopsy-proved IgAN in Peking University First Hospital and 589 geographically and ethnically matched healthy controls, were enrolled in the present study. IgAN was defined by a renal biopsy demonstrating dominant IgA deposition in the mesangium on immunofluorescence microscopy and the secondary causes for the biopsy findings, such as clinical diagnosis of Henoch-Schönlein purpura, systemic lupus erythematosus or liver cirrhosis, were excluded.
Three hundred and eighty-four of the 527 IgAN patients were regularly followed and the mean follow-up duration was 31.3 AE 17.7 months. Clinical characteristics of the patients with IgAN, including age, systolic/diastolic blood pressure, serum creatinine, estimated glomerular filtration rate (eGFR) (using a modification of the modified diet in renal disease equation based on the Chinese chronic kidney disease (CKD) population) [13] , urinary protein excretion and time-average proteinuria during follow-up, were reviewed. The pathological classification of Haas was graded independently by two pathologists. The primary end point was estimated on the basis of a 50% increasing or doubling of serum creatinine from baseline, observed for at least two consecutive follow-up visits, or if the patient underwent renal replacement therapy.
The protocol for the genetic study was approved by the medical ethics committee of Peking University and informed written consent was obtained from all participants.
single neucleotide polymorphism selection
Two previous GWAS have associated the haplotype E1 (GCCT) and its tagging single neucleotide polymorphisms (SNPs) (rs4821480, rs2032487, rs4821481 and rs3752462) spanning introns 12-23 of the MYH9 gene with an excess risk of ESRD in African-Americans [11, 12] . More recently, in a dense mapping study, one of the highly associated SNPs in intron 23, rs4821480, was predicted as a functional splicing motif modifier [14] . Meanwhile, this association was further confirmed in both African and Hispanic American populations [9] , and other haplotypes, S1 and F1, were also reported to be associated with non-diabetic ESRD, even with stronger significance. Thus, based on this statistical evidence and functional speculation, we first focused on the refined risk haplotypes E-1, SI and F1. Based on HapMap data, as no variations for rs2032487 and rs4821481 in haplotype E1 were reported in Chinese, only rs3752462 and rs4821480 were investigated in the current study. In addition, there were no common polymorphisms in SNPs in both haplotype S1 and F1 except rs2413396 either. Therefore, rs2413396 was further studied. At the same time, in a Caucasian population, another SNP, rs11089788 [10] (intron 1), which was reported to show the most significant association with kidney function (serum creatinine), was further included.
Genotyping
Genomic DNA was isolated from whole blood using a modified salt extraction technique [15] . The SNP sites, rs3752462, rs4821480 and rs11089788, were genotyped using the TaqMan assay according to the protocol supplied by the manufacturer (Assay ID: C_2473811_1_ for rs3752462, C_28018582_10 for rs4821480 and C_31391727_10 for rs11089788; Applied Biosystems, Foster City, CA). Briefly, 20 ng genomic DNA was introduced into a reaction mixture consisting of TaqMan Genotyping Master Mix, forward and reverse primers and two TaqMan probes labeled by FAM and VIC dye, respectively. The thermal cycling condition was as follows: a pre-run at 95°C for 10 min; 40 cycles with a 15 s denaturation step at 95°C, followed by a 60°C annealing step for 1 min. All assays were conducted on an ABI Prism 7500 Instrument. The SDS software V1.3.1 plotted the results of the allelic discrimination on a scatter plot. Due to faulty genotyping, apparently caused by the close proximity of indel rs3842715, as reported, rs2413396 was genotyped by a restriction fragment length polymorphism assay. Amplification primers were 5#-CCAGCACCTCCCCGTGA-3#and 5#-GTGGAGAAGGTGATGCAG-GAG-3#, which skipped the indel rs3842715. The polymerase chain reaction (PCR) conditions were as follows: 94°C for 2 min, then 35 cycles of 94°C for 20 s, 65°C for 30 s, 72°C for 30 s and finally 72°C for 10 min. The PCR products were digested with HaeII (New England Biolabs) at 37°C overnight. Fragments were separated by electrophoresis on 3% agarose gels and stained with ethidium bromide. The T allele was designated if one 130-bp band was obtained, and the C allele was designated if 109bp was obtained (the fragment of 21 bp was not actually seen). Genotypes were further confirmed by direct sequencing of PCR products of homozygotes and heterozygotes.
Statistical analysis
Variables were expressed as mean AE SD or median with range (P25, P75), direct counting as well as proportion. The unpaired t-test was used for comparison of continuous data. Chi-square test was taken to associate between MYH9 polymorphisms and the susceptibility to IgAN. Multivariate survival analysis was performed with a Cox regression model to test the independent prognostic value. Box plots represent median, quartiles and ranges of slope of eGFR. Statistical analyses were performed by SPSS version 13.0 (SPSS, Chicago, IL), and two-sided P-values <0.05 were considered as significant.
Results
Clinical features of patients and controls
All the subjects were from Han ethnicity living in the North of China. The average age of IgAN patients was 34.4 AE 11.7 years, including 269 males (51.0%) and 258 females. The mean baseline systolic blood pressure and diastolic blood pressure of patients were 123.0 AE 15.6 mmHg and 79.0 AE 12.0 mmHg. Serum creatinine, eGFR and proteinuria were 104.0 AE 64.7 mmol/L, 84.7 AE 32.2 mL/min/ 1.73m 2 and 2.34 AE 2.41 g/day in average at the time of enrollment. The mean age of healthy controls was 31.9 AE 8.7 years, including 385 males (65.4%) and 204 females. Tables 1 and 2 show the allele frequencies and genotypes in the patients and controls. None of the genotypes in the controls or patients showed significant deviation (P > 0.05) from Hardy-Weinberg equilibrium.
Association between SNPs within MYH9 and susceptibility to IgAN
No significantly different distribution of rs3752462, rs4821480, rs11089788 and rs2413396 between the patients and controls was observed, no matter which alleletype level or genotype level (P > 0.05).
Since it was reported that in African-Americans, the E-1 haplotype (GCCT of rs4821480, rs2032487, rs4821481 and rs3752462) association with ESRD was stronger than any individual SNP associations [12, 16] , we further tested the possible association between haplotype E1 and disease susceptibility. However, the linkage disequilibrium (LD) analysis indicated that rs3752462 and rs4821480 were not in the same block (r 2 = 0, D# = 0), thus could provide no more information than that from a single marker.
Association between MYH9 genotypes and baseline characters of IgAN patients
The association of the patients' quantitive traits (including age, systolic and diastolic blood pressure, serum creatinine, eGFR and urinary protein excretion) at the time of renal biopsy and different combinations of genotypes of these three MYH9 SNPs (rs3752462, rs11089788 and rs2413396) were analyzed, and no significant differences were observed (P > 0.05). Meanwhile, no significantly different distribution of baseline histological grades was observed between groups (Table 3 , data were presented under recessive models which were reported to be the best fit). In addition, further dividing these continuous variables into dichotomous phenotypes also refuted any associations (data not shown).
Association between MYH9 genotypes and prognosis of IgAN patients during the follow-up
In the current large cohort with regular follow-up (6-98 months), we further analyzed the association of polymorphic variants of MYH9 with the patients' renal prognosis. It showed that a significant eGFR decline rate (slope of eGFR) was observed in patients with rs11089788 A allele (AA/AC) compared with patients without tA allele (C/C) (P = 0.021) (Figure 1 ). No such association was observed regarding rs3752462 and rs2413396 (Table 4) . Meanwhile, at the end of follow-up time, the ratio of patients who met the primary end points was similar between groups.
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Discussion
In recent years, increasing evidence implicated the importance of genetic factors in the development and progression of IgAN, a disease widely considered to be a polygenic disorder. Despite all the effort that was made and the significant progress that has been achieved in the genetic field of IgAN [17] [18] [19] , the genetic pathogenesis of IgAN needs to be further elucidated. GWAS, which has been applied to many complex trait diseases, is a powerful approach to identify novel candidate genes. However, as to the limits of GWAS, such as being time-consuming and costly, candidate genes-based genetic association study should not be neglected in the search for further pathogenic clues. Thus, in consideration of IgAN as a leading cause of ESRD in China, the application of data from GWAS in ESRD in the genetic study of IgAN is a reasonable strategy, and it may provide further information as well as broaden our view of pathogenesis of IgAN.
The MYH9 is a likely candidate gene for ESRD evidenced by recent GWAS [11, 12] . Strong associations between MYH9 gene polymorphisms and idiopathic or HIV-related focal segmental glomerulosclerosis, hypertension-associated ESRD were revealed in the ethnic group of AfricanAmericans. Within the many associated common variants of MYH9, the strongest signal was observed located on the 3# side of the MYH9 gene (the African-origin E-1 haplotype, consisting of rs4821480, rs2032487, rs4821481 and rs3752462). Haplotype E1 was also associated with urinary albumin-to-creatinine ratio in hypertensive African-Americans [20] . Further dense-mapping study by Nelson [14] refined the association studies and revealed one of the possible causal sequence variations in rs4821480, which may act in introducing splice changes. Such splicing change introduces a stop codon, which is likely to be a knockout effect, and eliminates the last 20 exons. Meanwhile, haplotype E1 SNPs were also confirmed to be associated with non-diabetic ESRD in both African and Hispanic American populations. Some new significant SNPs from haplotype S1 (including rs2413396) and F1 were reported to be stronger associated with non-diabetic ESRD in Hispanic Americans as well. In agreement with the findings in African-Americans, the MYH9 gene is also significantly associated with kidney function (serum creatinine), from the studies in Europeans by Pattaro et al. [10] . However, in their studies, the most significant SNPs, including rs11089788, were on the 5# side, quite different from SNPs detected earlier in African-Americans. The different conclusions may derive from genetic heterogeneity. But all in all, these studies securely established the possible importance of MYH9 in kidney disease, especially in ESRD, and revealed possible responsible sequence variation.
In the present study, we focused on such refined risk haplotype E1, S1 and F1 and the SNP rs11089788. Meanwhile, there are no polymorphisms in these SNPs excepts rs3752462, rs4821480, rs2413396 and rs11089788 in the Han people of Chinese based on HapMap data, similar to that of Caucasians. However, no polymorphism of rs4821480 was found in the present study. Although rs3752462 has a high heterozygosity in Chinese, LD analysis indicated that rs3752462 and rs4821480 were not in the same haplotype. The highly associated SNP rs3752462 in African-Americans (P-value range from 2.0 3 10 À5 to 4.0 3 10 À15 with OR 2.75-3.8) was not found to be associated with genetic susceptibility or progression of IgAN in our cohort and no associations between rs3752462 and serum creatinine, eGFR or urinary protein excretion were observed. The same results were observed regarding rs2413396. In the present study, we did not find any association between rs11089788 and the serum creatinine in IgAN patients at the time of renal biopsy, different from European populations. And no genetic association between SNP and clinical characteristics of IgAN at the time of renal biopsy, such as systolic blood pressure, diastolic blood pressure, eGFR and urinary protein excretion was observed as well. However, in our study, MYH9 SNP rs11089788 was involved in the progression of IgAN during the follow-up time. Cox regression indicated that this polymorphism was an independent risk factor for renal function decline independent of time-average proteinuria, pathological classification of Haas and serum creatinine. It may indicate that allele A of rs11089788 may confer a risk of rapid decline in renal function in IgAN patients. Our data suggest that MYH9 may play important roles in mediating nephropathy in the context of IgAN.
The most significantly associated rs11089788 (both in CEU and our study) is at the 5# side of MYH9 gene. This polymorphism may influence the MYH9 gene function or be in linkage with another functional locus influencing its performance indirectly; however, the precise mechanism is unknown. So far, all of the genetic studies of CKD are just based on association. The causes of the profound MYH9 effect on kidney disease are still not clear. The MYH9 expression present in essentially every cell, is the cellular motor that contributes to motility, adhesion, intra-cellular trafficking and cytokinesis. MYH9 expression occurs in the glomerulus, specifically the podocyte, peritubular capillaries and tubules [21, 22] . Previously, specific MYH9 non-synonymous mutations have been associated with giant platelet syndromes or MYH9-related disease, which include thrombocytopaenia and frequently sensori-neural deafness and/or glomerulonephritis [8, 21] . Mutations in MYH9 are involved in focal podocyte foot process effacement and loss of podocyte slit diaphragms [7, 23] . Aberrant expression, location or function alteration of MYH9 due to functional variants may lead to abnormal myosin and damage to the cytoskeleton of the podocyte and tubular cells, further lead to proteinuria and/or haematuria and even renal dysfunction. Although the current data supported MYH9 as an important gene associated with ESRD caused by IgAN in Chinese, the definitive causal variants are not yet clear. Risk variants may influence the MYH9 gene function or be in linkage with other near functional loci. Just like a recent study published in Science, it was reported that an adjacent gene, APOL1 rather than the MYH9 gene, was more significantly associated with ESRD in African-Americans based on statistical significance and some functional tests of missense mutations (G1 and G2) of APOL1 in the infection by Trypanosoma brucei rhodesiense [24] [25] [26] [27] . Therefore, to analyse the association between APOL1 and IgAN-associated ESRD, further LD analysis may be needed in our IgAN cohort. However, G1 and G2 in APOL1 were rare variants in Chinese, Japanese or European individuals, which was different from Yoruba. Additionally, there were no further studies to elucidate the mechanism of APOL1 in other populations without polymorphisms in these SNPs. Currently, it is difficult for us to do further research, but in the future, the mutation screening of APOL1 in our IgAN cohort will be needed. Although APOL1, rather than MYH9, may be a plausible candidate gene for ESRD with higher OR in African-Americans, non muscle myosin heavy chain IIA (NMHC-IIA), production of the MYH9 gene, was reported to be involved in the Herpes simplex virus-1 infection from a recently published study [28] . Overall, as risk variants in MYH9 and APOL1 are in strong LD, the association of MYH9 and ESRD caused by IgAN in our study likely give some information and further studies will be required to establish the definitive disease-associated variants in other populations.
Our study also has some limitations. In the present study, we chose four SNPs that were reported to be disease/traits associated with the most significance based on previous reports. As to determine the causal SNP in current GWAS is quite difficult, further deep sequencing data may be deserved.
In conclusion, by our replication study in Chinese IgAN patients, we confirmed that the MYH9 gene was associated with ESRD caused by IgAN in our cohort. MYH9 polymorphism, rs11089788, may be an independent risk factor for renal function decline in IgAN patients in China. We supported the idea that MYH9 might be a potential candidate gene involved in kidney disease. Further pilot studies are needed to determine whether it can be a useful biomarker for prognosis, and in order to acquire more precise mechanisms, it may need multiple replications in different populations and more densemapping for common as well as rare variants. 
